Northfield Labs, Inc. (NFLD) is Tackling a Long Standing Medical Challenge
QualityStocks (April 1st, 2009) Writes:
Northfield Laboratories, Inc. is gradually tackling one of the most challenging and long-standing problems in the medical field, the development of a hemoglobin-based oxygen-carrying red blood cell substitute, which some are simply calling artificial blood.
Imagine you or a family member is rushed to the hospital after a serious accident. Blood loss has robbed the body of oxygen, and an urgent, large-volume transfusion is needed. But there’s a problem. The hospital doesn’t have access to enough blood, at least of the type needed. It’s exactly the scenario Northfield Labs has been working on for many years to address.
Although attempts have been made to achieve this major medical goal, the process is tricky, and nothing has yet been approved in the United States. But Northfield, considered a leader in developing a hemoglobin-based oxygen-carrying red blood cell substitute, believes that will be changing.
PolyHeme®, Northfield’s product, is a human hemoglobin-based oxygen-carrying
...Evanston, Fda, Illinois, life-saving tool;, Northfield Laboratories Inc.;, Northfield Labs Inc.;, PolyHeme®;, Small & Micro Cap, United States


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)




